| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.017 | 0.8 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.8 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.044 | 0.8 |
| mRNA | Bryostatin 1 | FIMM | pan-cancer | AAC | -0.04 | 0.8 |